Tofacitinib for Ankylosing Spondylitis User Reviews
Brand names: Xeljanz, Xeljanz XR, Xeljanz Oral Solution
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
Learn more about Ankylosing Spondylitis
Care guides
Symptoms and treatments
More about tofacitinib
- Check interactions
- Compare alternatives
- Reviews (172)
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
- En español
"I took Xeljanz XR 5 mg for ankylosing spondylitis (AS) for a year. It worked great. I was not in pain, and my eyes didn't become inflamed the whole time I was taking it. My doctor decided for whatever reason, probably because Xeljanz has some very harsh side effects, to put me on Rinvoq, another JAK inhibitor. I was on that for two months. I gained 8 lbs in those two months. My A1C jumped several points, which explains the weight gain. I was becoming diabetic on Rinvoq. I went back to Xeljanz and developed diverticulitis. At the end of that year, my A1C had also jumped up, and I am now prediabetic despite losing 15 lbs. I quit Xeljanz, vowed to never take a JAK inhibitor again, and my eyes instantly inflamed. So the drug works, but with bad side effects. And I was taking much less than the recommended dosage. Rinvoq has since been given a red flag warning as it is prone to the development of heart disease."